Results 1 to 10 of about 141,595 (167)

Detecting Hepatitis B Surface Antigen Mutants

open access: yesEmerging Infectious Diseases, 2006
Hepatitis B viral mutants can emerge in patients as a result of selection pressure from either immune response or treatment options. Mutations that occur within the immunodominant epitopes of hepatitis B surface antigen (HBsAg) allow mutant virus to ...
Paul F. Coleman
doaj   +3 more sources

Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City

open access: yesAdvanced Medical Journal, 2023
Background and objectives:Hepatitis-B virus is one of the most serious and prevalent health problems. Vaccination against Hepatitis-B virus is the most effective way of preventing infection and transmission of the virus.
Razhan Sabah Hassan, Ali Hattem Bayati
doaj   +1 more source

Proteins of hepatitis B surface antigen [PDF]

open access: yesJournal of Virology, 1977
Purified 22-nm forms of hepatitis B surface antigen (Hbsag) representing the three major antigenic subtypes (adw, ayw, and adr) were analyzed for their constituent polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. No consistent difference in either the number or relative distributions of the polypeptides was observed for the ...
J W, Shih, J L, Gerin
openaire   +2 more sources

Hepatitis B surface antigen and associated factors among mothers who had antenatal care contact in Attat Hospital, southern Ethiopia

open access: yesSAGE Open Medicine, 2021
Introduction: Hepatitis B virus is a viral infection which can cause both acute and chronic liver disease. Predominately, this virus transmitted through the mother-to-child route.
Yohannes Fikadu Geda   +3 more
doaj   +1 more source

High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. [PDF]

open access: yesPLoS ONE, 2012
IntroductionThere is no data on the relationship between hepatitis B surface antigen (HBsAg) levels and liver fibrosis in hepatitis B e antigen (HBeAg)-positive patients with chronic hepatitis B (CHB).MethodsSerum HBsAg and HBV DNA levels in HBeAg ...
Wai-Kay Seto   +7 more
doaj   +1 more source

The Incidence Of Hepatitis B Surface Antigen Positive Pregnant Women Admitted and Delivered at Camiguin General Hospital, Mambajao, Camiguin

open access: yesJPAIR, 2008
This study sought to investigate the incidence of mothers who are Hepatitis B surface antigen positive at Camiguin General Hospital for the month of December 2005 and January 2006.
Expeditha I. Bandiola   +1 more
doaj   +1 more source

Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle west region of Brazil

open access: yesMemorias do Instituto Oswaldo Cruz, 2001
The prevalence of antibodies to hepatitis B core antigen in 552 prime blood donors was of 9.4%. The majority (71.2%) has antibodies to hepatitis B surface antigen. The hepatitis B surface antigen was present in 0.7%, all of them antibodies to hepatitis B
José Ivan Aguiar   +5 more
doaj   +1 more source

Seroprevalence of Hepatitis B Viral Markers Among Freshmen — 20 Years After Mass Hepatitis B Vaccination Program in Taiwan

open access: yesJournal of the Formosan Medical Association, 2007
The nationwide hepatitis B vaccination program in Taiwan was well known for its efficacy in reducing the carrier rate of hepatitis B and the morbidity and mortality of hepatitis B-related diseases among children.
Hsien-Cheng Chang   +4 more
doaj   +1 more source

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance

open access: yesJGH Open, 2020
Background and Aim A low hepatitis B surface antigen (HBsAg) level is reported to be predictive of future HBsAg seroclearance. A hospital‐based cohort study was conducted to clarify the clinical features of patients with low HBsAg levels and to ...
Hideaki Taniguchi   +4 more
doaj   +1 more source

Stopping nucleos(t)ide analog treatment in chronic hepatitis B — Who and when?

open access: yesLiver Research, 2017
Nucleos(t)ide analogs (NAs) are one of the first-line treatments for chronic hepatitis B (CHB) infection. NAs are highly efficient in suppressing viral replication but are associated with a low rate of hepatitis B surface antigen (HBsAg) seroclearance ...
Suzette Grace R. Kho-Herman   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy